PKB receives investment from OMRON ventures to accelerate growth

Gurpreet SaraiNews

Patients Know Best announced today that it has received a strategic investment from OMRON Ventures, the venture capital arm of the OMRON group. OMRON’s healthcare business is a global leader in blood pressure monitors and other medical devices.

OMRON Ventures led an equity investment round in Patients Know Best (PKB), which was supported by existing investors including Balderton Capital.

From left to right: Richard Smith, Chairman at PKB, Rob Moffat, Partner at Balderton Capital,  Mohammad Al-Ubaydli, CEO at PKB and Tomoko Inoue, CEO at OMRON Ventures.

Patients Know Best collects patient data from healthcare providers and shares it quickly, safely and effectively to give patients, carers and care teams immediate access to vital information like appointment letters, care plans, medication lists, test results, allergies and details of previous attendances and discharge summaries.

This partnership represents a significant milestone in PKB’s history. Since its launch in 2010, PKB has become the leading provider of personal health records in the UK, and is currently in use at more than 60 hospitals in the UK, the Netherlands and Germany. This investment is set to accelerate the company’s rapid business growth globally and further diversify its digital platform.

Dr Mohammad Al-Ubaydli, CEO and founder of Patients Know Best, said: “We are delighted to announce this partnership. This investment will allow us to go further, faster in a global market. We look forward to expanding the connected device offering on PKB’s platform, and giving patients, carers and care teams access to vital monitoring information in real-time to more effectively manage care.”

Tomoko Inoue, CEO of OMRON Ventures, said: “We are excited to partner with the creators of the world’s first and truly patient-centered health management platform. PKB’s mission aligns strongly with our goal of empowering the patient and delivering innovative data-driven health solutions for the digital health era.”